Cases 51 - 60 of 110
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2019cv01674
Plaintiff:
Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company and others
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Arena Pharmaceuticals, Inc. et al v. Aurobindo Pharma Limited et al
as 1:2019cv00811
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Eisai Inc., 356 Royalty Inc. and Arena Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al. v. Aurobindo Pharma, Ltd. et al.
as 1:2019cv00748
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma, Ltd. and Eugia Pharma Specialties Ltd.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
Millennium Pharmaceuticals, Inc. v. Aurobindo Pharma USA Inc. et al
as 1:2019cv00471
Plaintiff:
Millennium Pharmaceuticals, Inc.
Defendant:
Aurobindo Pharma Limited and Aurobindo Pharma USA Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Aurobindo Pharma Limited et al
as 1:2019cv00103
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Aurobindo Pharma Limited et al
as 1:2019cv00105
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited
Plaintiff:
Genentech, Inc. and InterMune, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2018cv01757
Defendant:
Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant:
Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
